At this stage, we intend to reengage with the New York based Investment Banks with view to holding an auction. This auction will not only be for PeriCoach but also for the AutoStart Burette.
I will now address our endeavours to commercialise the ASB. In discussions with major burette multinationals it is clear that they will only licence our ASB technology if they can see that our burette is making inroads into their market share in first world hospitals. In June this year we announced the successful inclusion of our AutoStart Infusion system onto the Queensland Health purchasing schedule. It is our hope that the success of the ASB in Queensland Hospitals will be able to be used as a reference when licencing the ASB technology to major players in the US.
ALT Price at posting:
0.8¢ Sentiment: Buy Disclosure: Held
